Could a Chemo-Immuno combo boost cancer fight before surgery?
Disease control
Recruiting now
This phase 2 trial tests whether combining the chemotherapy 5-azacytidine with the immunotherapy nivolumab can make HPV-related head and neck cancer more responsive to treatment. About 50 people with resectable tumors will receive one or both drugs before surgery. The goal is to …
Phase: PHASE2 • Sponsor: Barbara Burtness • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC